BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 36430206)

  • 1. Carborane-Containing Folic Acid
    Gruzdev DA; Telegina AA; Levit GL; Solovieva OI; Gusel'nikova TY; Razumov IA; Krasnov VP; Charushin VN
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEGylated liposome encapsulating nido-carborane showed significant tumor suppression in boron neutron capture therapy (BNCT).
    Lee W; Sarkar S; Ahn H; Kim JY; Lee YJ; Chang Y; Yoo J
    Biochem Biophys Res Commun; 2020 Feb; 522(3):669-675. PubMed ID: 31787237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
    Genady AR
    Eur J Med Chem; 2009 Jan; 44(1):409-16. PubMed ID: 18407378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective Neuropeptide Y Conjugates with Maximized Carborane Loading as Promising Boron Delivery Agents for Boron Neutron Capture Therapy.
    Worm DJ; Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Med Chem; 2020 Mar; 63(5):2358-2371. PubMed ID: 31589041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated with
    Vorobyeva MA; Dymova MA; Novopashina DS; Kuligina EV; Timoshenko VV; Kolesnikov IA; Taskaev SY; Richter VA; Venyaminova AG
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and properties of nido-carborane-specific monoclonal antibodies for potential use in boron neutron capture therapy for cancer.
    Pak RH; Primus FJ; Rickard-Dickson KJ; Ng LL; Kane RR; Hawthorne MF
    Proc Natl Acad Sci U S A; 1995 Jul; 92(15):6986-90. PubMed ID: 7624355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative evaluation of boron neutron capture therapy (BNCT) drugs for boron delivery and retention at subcellular-scale resolution in human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S; Ahmad T; Barth RF; Kabalka GW
    J Microsc; 2014 Jun; 254(3):146-56. PubMed ID: 24684609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Application of Carboranes for Boron Neutron Capture Therapy (BNCT): Structure, Formulation and Analytical Methods for Detection.
    Marforio TD; Carboni A; Calvaresi M
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water-soluble BODIPY-nido-carborane nanoparticles applied to biocompatibility tumor cell imaging.
    Dai D; Lian G; He X; Feng J; Jin G
    Photochem Photobiol Sci; 2022 Feb; 21(2):185-194. PubMed ID: 35061200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Selective Carborane-Functionalized Gastrin-Releasing Peptide Receptor Agonist as Boron Delivery Agent for Boron Neutron Capture Therapy.
    Hoppenz P; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Lerchen HG; Köbberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Org Chem; 2020 Feb; 85(3):1446-1457. PubMed ID: 31813224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and characterization of nido-carborane-cobalamin conjugates.
    Hogenkamp HP; Collins DA; Live D; Benson LM; Naylor S
    Nucl Med Biol; 2000 Jan; 27(1):89-92. PubMed ID: 10755651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carboranes as unique pharmacophores in antitumor medicinal chemistry.
    Chen Y; Du F; Tang L; Xu J; Zhao Y; Wu X; Li M; Shen J; Wen Q; Cho CH; Xiao Z
    Mol Ther Oncolytics; 2022 Mar; 24():400-416. PubMed ID: 35141397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact on Glioblastoma U87 Cell Gene Expression of a Carborane Cluster-Bearing Amino Acid: Implications for Carborane Toxicity in Mammalian Cells.
    He T; Chittur SV; Musah RA
    ACS Chem Neurosci; 2019 Mar; 10(3):1524-1534. PubMed ID: 30475580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modular Synthetic Approach to Carboranyl‒Biomolecules Conjugates.
    Kellert M; Friedrichs JJ; Ullrich NA; Feinhals A; Tepper J; Lönnecke P; Hey-Hawkins E
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33916755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Self-Forming Nanosized DDS Particles for BNCT: Utilizing A Hydrophobic Boron Cluster and Its Molecular Glue Effect.
    Fithroni AB; Kobayashi K; Uji H; Ishimoto M; Akehi M; Ohtsuki T; Matsuura E
    Cells; 2022 Oct; 11(20):. PubMed ID: 36291173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoinduced Selective B-H Activation of
    Xu S; Zhang H; Xu J; Suo W; Lu CS; Tu D; Guo X; Poater J; Solà M; Yan H
    J Am Chem Soc; 2024 Mar; 146(11):7791-7802. PubMed ID: 38461434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stable meta-carborane enables the generation of boron-rich peptide agonists targeting the ghrelin receptor.
    Worm DJ; Els-Heindl S; Kellert M; Kuhnert R; Saretz S; Koebberling J; Riedl B; Hey-Hawkins E; Beck-Sickinger AG
    J Pept Sci; 2018 Oct; 24(10):e3119. PubMed ID: 30168238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-Soluble
    Nakagawa F; Kawashima H; Morita T; Nakamura H
    Cells; 2020 Jul; 9(7):. PubMed ID: 32635272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of carborane-containing porphyrins as tumour targeting agents for boron neutron capture therapy.
    Miura M; Micca PL; Fisher CD; Gordon CR; Heinrichs JC; Slatkin DN
    Br J Radiol; 1998 Jul; 71(847):773-81. PubMed ID: 9771389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and Structure of
    Druzina AA; Zhidkova OB; Dudarova NV; Kosenko ID; Ananyev IV; Timofeev SV; Bregadze VI
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33498488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.